Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Timo Vesikari, Paula Peyrani, Chris Webber, Marie Van Der Wielen, Brigitte Cheuvart, Nathalie De Schrevel, Emmanuel Aris, Mark Cutler, Ping Li & John L. Perez. (2020) Ten-Year Antibody Persistence and Booster Response to MenACWY-TT Vaccine After Primary Vaccination at 1-10 Years of Age. Human Vaccines & Immunotherapeutics 16:6, pages 1280-1291.
Read now
Read now
Jamie Findlow, Paul Balmer & Ray Borrow. (2019) A review of complement sources used in serum bactericidal assays for evaluating immune responses to meningococcal ACWY conjugate vaccines. Human Vaccines & Immunotherapeutics 15:10, pages 2491-2500.
Read now
Read now
Erman Tritama, Catur Riani, Indra Rudiansyah, Arip Hidayat, Siti Azizah Kharisnaeni & Debbie Sofie Retnoningrum. (2018) Evaluation of alum-based adjuvant on the immunogenicity of salmonella enterica serovar typhi conjugates vaccines. Human Vaccines & Immunotherapeutics 14:6, pages 1524-1529.
Read now
Read now
Giulia Piccini, Alessandro Torelli, Elena Gianchecchi, Simona Piccirella & Emanuele Montomoli. (2016) Fighting Neisseria meningitidis: past and current vaccination strategies. Expert Review of Vaccines 15:11, pages 1393-1407.
Read now
Read now
Beatriz P. Quiambao, Hermant Jain, Ashish Bavdekar, Anand Prakash Dubey, Devayani Kolhe, Véronique Bianco, Marie Van der Wielen & Jacqueline M. Miller. (2016) Persistence of the immune response two years after vaccination with quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine (MenACWY-TT) in Asian adolescents. Human Vaccines & Immunotherapeutics 12:8, pages 2162-2168.
Read now
Read now
Aia Assaf-Casals & Ghassan Dbaibo. (2016) Meningococcal quadrivalent tetanus toxoid conjugate vaccine (MenACWY-TT, Nimenrix™): A review of its immunogenicity, safety, co-administration, and antibody persistence. Human Vaccines & Immunotherapeutics 12:7, pages 1825-1837.
Read now
Read now
Timo Vesikari, Aino Forsten, Veronique Bianco, Marie Van der Wielen & Jacqueline M Miller. (2016) Antibody persistence up to 5 years after vaccination of toddlers and children between 12 months and 10 years of age with a quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine. Human Vaccines & Immunotherapeutics 12:1, pages 132-139.
Read now
Read now
Marco Aurélio Sáfadi, Julie A Bettinger, Gabriela Moreno Maturana, Godwin Enwere & Ray Borrow. (2015) Evolving meningococcal immunization strategies. Expert Review of Vaccines 14:4, pages 505-517.
Read now
Read now
Carine P Hedari, Rima W Khinkarly & Ghassan S Dbaibo. (2014) Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal disease. Infection and Drug Resistance 7, pages 85-99.
Read now
Read now
Michael E Pichichero. (2013) Protein carriers of conjugate vaccines. Human Vaccines & Immunotherapeutics 9:12, pages 2505-2523.
Read now
Read now
Articles from other publishers (16)
Lidia Serra, Chris Webber, Cindy Burman, Patrizia Bueti, Maria Gorruso & Susan Mather. (2022) Clinical trial and postmarketing safety experience with MenACWY-TT, a meningococcal group A, C, W, and Y tetanus conjugate vaccine. Vaccine 40:49, pages 7014-7021.
Crossref
Crossref
Chris Webber, Paula Peyrani, Paul Balmer & Lidia Serra. (2020) Persistence of bactericidal antibodies following primary and booster MenACWY-TT vaccination of toddlers: A review of clinical studies. Vaccine 38:27, pages 4236-4245.
Crossref
Crossref
Jessica Presa, Jamie Findlow, Jelena Vojicic, Scott Williams & Lidia Serra. (2019) Epidemiologic Trends, Global Shifts in Meningococcal Vaccination Guidelines, and Data Supporting the Use of MenACWY-TT Vaccine: A Review. Infectious Diseases and Therapy 8:3, pages 307-333.
Crossref
Crossref
Jamie Findlow & Markus Knuf. (2019) Immunogenicity and safety of meningococcal group A, C, W and Y tetanus toxoid conjugate vaccine: review of clinical and real-world evidence. Future Microbiology 14:7, pages 563-580.
Crossref
Crossref
Luis Rivera, Tino F. Schwarz, Kyung-Hyo Kim, Yun-Kyung Kim, Ulrich Behre, Sung-Ho Cha, Dae Sun Jo, Jacob Lee, Jin-Soo Lee, Brigitte Cheuvart, Archana Jastorff & Marie Van der Wielen. (2018) Immunogenicity and safety of the quadrivalent meningococcal vaccine MenACWY-TT co-administered with a combined diphtheria-tetanus-acellular pertussis vaccine versus their separate administration in adolescents and young adults: A phase III, randomized study. Vaccine 36:31, pages 4750-4758.
Crossref
Crossref
Markus Knuf, Klaus Helm, Devayani Kolhe, Marie Van Der Wielen & Yaela Baine. (2018) Antibody persistence and booster response 68 months after vaccination at 2–10 years of age with one dose of MenACWY-TT conjugate vaccine. Vaccine 36:23, pages 3286-3295.
Crossref
Crossref
Nicola P. Klein, Tomas Habanec, Pavel Kosina, Nirmish R. Shah, Devayani Kolhe, Jacqueline M. Miller, Marjan Hezareh & Marie Van der Wielen. (2018) Immunogenicity and safety of the quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine (MenACWY-TT) in splenectomized or hyposplenic children and adolescents: Results of a phase III, open, non-randomized study. Vaccine 36:17, pages 2356-2363.
Crossref
Crossref
Jose Manuel Merino Arribas, Alfonso Carmona Martínez, Michael Horn, Xavier Maria Perez Porcuna, Maria del Carmen Otero Reigada, Josep Marès Bermúdez, Fernando Centeno Malfaz, Mariano Miranda, Maria Mendez, Miguel Angel Garcia Cabezas, Christoph Wittermann, Gerhard Bleckmann, Thomas Fischbach, Devayani Kolhe, Marie van der Wielen & Yaela Baine. (2017) Safety and Immunogenicity of the Quadrivalent Meningococcal Serogroups A, C, W and Y Tetanus Toxoid Conjugate Vaccine Coadministered With Routine Childhood Vaccines in European Infants. Pediatric Infectious Disease Journal 36:4, pages e98-e107.
Crossref
Crossref
Nicola P. Klein, Yaela Baine, Devayani Kolhe, Carmen I. Baccarini, Jacqueline M. Miller & Marie Van der Wielen. (2016) Five-year Antibody Persistence and Booster Response After 1 or 2 Doses of Meningococcal A, C, W and Y Tetanus Toxoid Conjugate Vaccine in Healthy Children. The Pediatric Infectious Disease Journal 35:6, pages 662-672.
Crossref
Crossref
William Johnston, Brandon Essink, Judith Kirstein, Eduardo Forleo-Neto, Sandra Percell, Linda Han, Pavitra Keshavan & Igor Smolenov. (2016) Comparative Assessment of a Single Dose and a 2-dose Vaccination Series of a Quadrivalent Meningococcal CRM-conjugate Vaccine (MenACWY-CRM) in Children 2–10 Years of Age. Pediatric Infectious Disease Journal 35:1, pages e19-e27.
Crossref
Crossref
Charissa Fay Corazon Borja-Tabora, Cecilia Montalban, Ziad A. Memish, Dominique Boutriau, Devayani Kolhe, Jacqueline M. Miller & Marie Van der Wielen. (2015) Long-term immunogenicity and safety after a single dose of the quadrivalent meningococcal serogroups A, C, W, and Y tetanus toxoid conjugate vaccine in adolescents and adults: 5-year follow-up of an open, randomized trial. BMC Infectious Diseases 15:1.
Crossref
Crossref
Timo Vesikari, Aino Forsten, Veronique Bianco, Marie Van der Wielen & Jacqueline M. Miller. (2015) Immunogenicity, Safety and Antibody Persistence of a Booster Dose of Quadrivalent Meningococcal ACWY-tetanus Toxoid Conjugate Vaccine Compared with Monovalent Meningococcal Serogroup C Vaccine Administered Four Years After Primary Vaccination Using the Same Vaccines. Pediatric Infectious Disease Journal 34:12, pages e298-e307.
Crossref
Crossref
Roger Baxter, Yaela Baine, Devayani Kolhe, Carmen I. Baccarini, Jacqueline M. Miller & Marie Van der Wielen. (2015) Five-year Antibody Persistence and Booster Response to a Single Dose of Meningococcal A, C, W and Y Tetanus Toxoid Conjugate Vaccine in Adolescents and Young Adults. Pediatric Infectious Disease Journal 34:11, pages 1236-1243.
Crossref
Crossref
E.D.G. McIntosh, M. Bröker, J. Wassil, J.A. Welsch & R. Borrow. (2015) Serum bactericidal antibody assays – The role of complement in infection and immunity. Vaccine 33:36, pages 4414-4421.
Crossref
Crossref
Paolo Pellegrino, Valentina Perrone, Sonia Radice, Annalisa Capuano & Emilio Clementi. (2015) Immunogenicity of meningococcal quadrivalent (serogroup A, C, W135 and Y) tetanus toxoid conjugate vaccine: Systematic review and meta-analysis. Pharmacological Research 92, pages 31-39.
Crossref
Crossref
Helen Findlow & Ray Borrow. (2013) Immunogenicity and Safety of a Meningococcal Serogroup A, C, Y and W Glycoconjugate Vaccine, ACWY-TT. Advances in Therapy 30:5, pages 431-458.
Crossref
Crossref